TWI319711B - Hepatocyte growth factor hydrogel slow release preparation - Google Patents

Hepatocyte growth factor hydrogel slow release preparation

Info

Publication number
TWI319711B
TWI319711B TW091115896A TW91115896A TWI319711B TW I319711 B TWI319711 B TW I319711B TW 091115896 A TW091115896 A TW 091115896A TW 91115896 A TW91115896 A TW 91115896A TW I319711 B TWI319711 B TW I319711B
Authority
TW
Taiwan
Prior art keywords
growth factor
slow release
hepatocyte growth
release preparation
hydrogel slow
Prior art date
Application number
TW091115896A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19052974&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI319711(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Application granted granted Critical
Publication of TWI319711B publication Critical patent/TWI319711B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
TW091115896A 2001-07-18 2002-07-17 Hepatocyte growth factor hydrogel slow release preparation TWI319711B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001218870 2001-07-18

Publications (1)

Publication Number Publication Date
TWI319711B true TWI319711B (en) 2010-01-21

Family

ID=19052974

Family Applications (1)

Application Number Title Priority Date Filing Date
TW091115896A TWI319711B (en) 2001-07-18 2002-07-17 Hepatocyte growth factor hydrogel slow release preparation

Country Status (7)

Country Link
US (1) US20040253294A1 (zh)
EP (1) EP1415663B1 (zh)
JP (1) JP4878730B2 (zh)
DE (1) DE60229399D1 (zh)
HK (1) HK1065713A1 (zh)
TW (1) TWI319711B (zh)
WO (1) WO2003007982A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004115413A (ja) * 2002-09-25 2004-04-15 Yasuhiko Tabata 冠状動脈狭窄または閉塞治療用徐放性製剤
JP4459543B2 (ja) * 2003-03-17 2010-04-28 株式会社メドジェル 徐放性ハイドロゲル製剤
WO2004089400A1 (ja) * 2003-04-01 2004-10-21 Yasuhiko Tabata 心筋症治療剤
WO2004089401A1 (ja) * 2003-04-01 2004-10-21 Yasuhiko Tabata 虚血治療剤
US20070142279A1 (en) * 2004-03-09 2007-06-21 Hiroshi Kubo Agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor
US7919112B2 (en) * 2004-08-26 2011-04-05 Pathak Holdings, Llc Implantable tissue compositions and method
WO2006046584A1 (ja) * 2004-10-26 2006-05-04 Santen Pharmaceutical Co., Ltd. 視細胞障害治療剤
JP4685090B2 (ja) * 2005-02-14 2011-05-18 株式会社メドジェル 医療用ハイドロゲル
DE102005054937A1 (de) * 2005-11-17 2007-05-24 Gelita Ag Angiogenese förderndes Substrat
DE102007024239A1 (de) * 2007-05-16 2008-11-20 Gelita Ag Angiogenese förderndes Substrat
DE102007051059B4 (de) * 2007-10-18 2014-04-03 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Bioverbundmaterial für die kontrollierte Freisetzung von Wirkstoffen
JP5248519B2 (ja) 2007-11-07 2013-07-31 小野薬品工業株式会社 Ｓｄｆ−１を含有してなる徐放性組成物
MY148573A (en) * 2009-05-15 2013-04-30 Univ Sains Malaysia A method to differentiate the gelatin capsule of the porcine source from the bovine source
US8895508B2 (en) 2009-07-24 2014-11-25 Yasuhiki Tabata Methods for corneal endothelial proliferation using bFGF sustained-release gelatin hydrogel particles
CA2849472A1 (en) * 2013-04-22 2014-10-22 Nitto Denko Corporation Crosslinked gelatin support and support for controlled release of physiologically active substance using the same
CN104593779B (zh) * 2015-01-21 2018-02-16 北京科技大学 一种低pH可控释放的智能缓蚀剂的制备方法
CN107374662B (zh) * 2017-07-31 2020-12-18 东软医疗系统股份有限公司 一种放射源制备及相关方法、放射源及pet系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059213A (en) * 1990-03-26 1991-10-22 United States Surgical Corporation Spiroid braided suture
JP3977452B2 (ja) * 1995-02-27 2007-09-19 敏一 中村 動脈疾患治療剤
CA2218145C (en) * 1997-04-14 2008-01-08 Toshikazu Nakamura Method of treating dilated cardiomyopathy
DE60009525T2 (de) * 1999-09-30 2005-02-03 Kaken Pharmaceutical Co., Ltd. Herstellung eines medikamentes zur verbesserten heilung des sternums nach einer sternotomie
EP1223959B1 (en) * 1999-10-22 2007-05-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain

Also Published As

Publication number Publication date
US20040253294A1 (en) 2004-12-16
DE60229399D1 (de) 2008-11-27
EP1415663A4 (en) 2006-06-07
JP4878730B2 (ja) 2012-02-15
HK1065713A1 (en) 2005-03-04
WO2003007982A1 (fr) 2003-01-30
EP1415663A1 (en) 2004-05-06
JPWO2003007982A1 (ja) 2004-11-04
EP1415663B1 (en) 2008-10-15

Similar Documents

Publication Publication Date Title
TWI347202B (en) Controlled release preparation
TWI319711B (en) Hepatocyte growth factor hydrogel slow release preparation
AU2001282942A1 (en) Wireless support for brassiere
GB0106588D0 (en) Tissue distracter
AU2002357049A1 (en) Methods for preparing 0-desmethylvenlafaxine
AU2002342653A8 (en) Modified growth hormone
PT2343079E (pt) Técnica e dispositivo de preparação de células em suspensão
EP1333853A4 (en) GROWTH FACTOR COMPLEX
GB2360940B (en) Patient support
PL363283A1 (en) Device for artificial respiration
GB0115385D0 (en) Novel preparation
GB0123517D0 (en) Growing system
GB0105449D0 (en) Limb support
GB0218570D0 (en) Daughter-card structural support
GB0118009D0 (en) Novel preparation
AU6065901A (en) Feline hepatocyte growth factor
GB0127877D0 (en) Skin preparation
GB0103339D0 (en) Limb support
GB0118836D0 (en) Growth factor isoform
GB0111389D0 (en) Controlled release formulations
GB0100265D0 (en) Diphosphine compounds and methods for their preparation
AU145525S (en) Bait support
GB0027965D0 (en) Porous tissue support
HU0100006V0 (en) Bobber
HK1026819A2 (en) Split-type transceiver

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees